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Abstract
Connexins, Kv-type ion channels, and pannexins have a dominant role in maintaining the 
potassium ion homeostasis in the cochlea. The cellular background currents are sustained 
by Kir2.1 ion channels; however, their involvement in the hearing system is less clear. In 
this study, the mutations of gap junction proteins beta 2 (GJB2), beta 3 (GJB3) and beta 6 
(GJB6) were screened in the white Caucasian population in Hungary using gene mapping 
and immunofluorescence methods from translated proteins of these genes—connexins on 
blood cells. Expression of connexins and Kir2.1 ion channels was investigated in the blood 
cells of deaf patients prior to cochlear implantation, and the results show significantly 
decreased amounts of connexin26 and connexin43. In addition, the coexpression of Kir2.1 
ion channels with synapse-associated 97 proteins was partially impaired. Our investiga-
tion revealed a reduced level of Kir2.1 channels in deaf patients indicating a crucial role 
for the functional Shaker superfamily of K+ channels in the non-diseased hearing system.
Keywords: hearing loss, cochlea, GJB gene mutation, connexin26, connexin43, Kir2.1 
ion channels, lymphocytes
1. Introduction
Mutations in connexin26 (Cx26) and connexin30 (Cx30) have frequently been associated with 
hearing loss and deafness, and some Cx26 mutations have also been found to contribute to 
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over 50% of hearing loss or nonsyndromic deafness cases in different human populations 
investigated in the last decades [1–6].
Recently, a fast and new non-invasive method has been developed in our laboratory to identify 
mutated genes for GJB2 leading to hearing loss or deafness [7]. This method has allowed us to 
collect and store the dried blood spots (DBS) in Guthrie cards for mutation analysis or expressed 
proteins of genes. The early detection of genetic mutations for inner ear impairment is crucial 
to provide hearing rehabilitation with an outstanding functional outcome, i.e. to maintain the 
development of the peripheral and central auditory pathway for unhindered future benefits. 
There are a number of modern technologies in the field of cochlear implantation and to fulfill 
this aim it is crucial to address the audiological and logopedical progress in a timely manner.
Cx26 and connexin43 (Cx43) have a major role in cell-to-cell interactions and in the perme-
ability of the channels for diverse ions and small molecules, which maintain the physiological 
condition of the cochlea [1, 8]. Connexins form hemichannels in the cochlea where the Cx26 
channels are the most abundant and are involved in the potassium-recycling pathway of the 
cochlea. Translated proteins from GJ genes make up channels by head-to-head docking of two 
connexin hexamers referred to as hemichannels (HCs) or connexons; one from each neighbor-
ing cell [9, 10]. Cx26 proteins were localized in the outer membrane of the cochlea.
The position of mutations in the GJB2 gene (Cx26 protein) is different across certain popula-
tions. The known mutation in the populations of northern European descent is a base pair 
deletion at position 35 in the GJB2 gene (known as 35delG; Cx26 protein) while the 235delC 
mutation, which occurs more frequently in Asian populations, misses a base pair at position 
235 (Cx26 protein) [11–13]. Furthermore, patients with a single base pair deletion at posi-
tion 167 (167delT) (Cx26 protein) are commonly found in communities of eastern European 
(Ashkenazi) Jewish ancestry [14, 15].
Different connexins may be important factors in the flawless cell-to-cell interactions that 
maintain the fast electrogenic mechanisms between the cochlea and neuronal system [16]. 
Other ion currents are also involved in this process. The voltage-dependent inward rectifier 
potassium current (IK1) has a role in maintaining the resting membrane potential, contributing 
to the beginning and the final repolarization in all cells. The IK1 current in different tissues is 
sustained mostly by Kir2.x (Kir2.1, Kir2.2, and Kir2.3) ion channels [17–23]. Auxiliary sub-
units and the synapse-associated protein 97 (SAP97) modulate the function of these channels 
[24, 25]. IK1 currents have a fundamental role in muscle cells, but their molecular background 
in the hearing system is still uncertain. We have limited information on the impact of the 
altered gap-junctions [26] and Kir2.1 in the inner membrane of the cochlea [20, 21, 27], the 
neural connection and the expressed potassium ion channels on blood cells. The exploration 
of the type and mechanism of these channels is one of the aims of the present work.
Hereditary hearing diseases are known to be associated with mutations, such as the auto-
somal recessive non-syndromic hearing loss (ARNSHL), seizures, sensorineural deafness 
[5, 28–30], Pendred syndrome (PDS) [5, 29–31], deafness [7, 27–35], and rarely the hearing 
loss overlaps with Andersen-Tawil syndrome [2, 36, 37]. The Andersen-Tawil syndrome is 
characterized by mutated KCNJ2 genes expressing malfunctioned Kir2.1 proteins, which 
leads to functional abnormalities and causing deafness with cardiomyopathy [36–38].
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The IK1 current is sustained -by ion channels that consist of heteromeric assemblies of Kir2.1, 
Kir2.2, and Kir2.3 α-subunits [22, 39]. This current significantly contributes to the maintenance 
and regulation of the resting membrane potential [17, 40] and strongly affects the final repo-
larization of the action potential (AP) [8, 9, 17, 18, 41]. The Kir2.x channels are under the con-
trol of the intracellular scaffolding, trafficking and regulatory proteins, which strongly adjust 
their physiological functions. Kir2.x isoforms colocalize with membrane associated guanylate 
kinase (MAGUK) proteins [24, 42]. One of these is the SAP97 anchoring protein, which has an 
important interaction with Kir2.x channel complexes in neuronal cells and myocytes [25, 42, 
43]. Various Kir2.x isoforms may cooperate differently with the MAGUK proteins in the com-
plexes that traffic Kir2.x ion channels to the plasma membrane (PM), and anchor and stabilize 
these channels into the sarcolemma of cardiac muscle [22, 25, 43]. The Kir2.1 channels may be 
exported from the Golgi in a signal-dependent manner and this process may be disrupted by 
certain diseases [44]. The age-dependent SAP97 expression in the human heart was evaluated 
for the first time in our laboratory [45], and it seems that the regulation and modulation of 
these ion channel complexes have a strong effect in the development of different tissue types 
in diverse hereditary diseases associated with cardiomyopathy and deafness too [36–39, 46]. 
These genes have demonstrated a gender differences and have been remodeled in cardiomy-
opathy [40, 41]. IK1 currents are active during the time course of AP [20, 21, 47, 48], but their 
molecular background basis is poorly characterized on blood cells.
Our hypothesis states that connexins and Kir2.x ion channels, which are impaired at the tran-
scription and translated protein level in deafness, have an essential function in the hearing 
system. The aim of this study was to monitor the mutations of expressed GJs and KCNJ2 
genes in the Hungarian population and to screen the expression of hearing-related genes and 
proteins involved in the maintenance of the ionic homeostasis in the cochlea. An additional 
goal was to find an opportunity to obtain cells from the body that present the disrupted ionic 
status control characteristic of the pathophysiological condition of deafness. For this pur-
pose, we used non-invasive methods to find the representative and irrevocable changes in 
peripheral blood cells of patients. Our group has previously demonstrated that connexin ion 
channels, especially the Cx26 mutations, are characteristic indicators in patients with hearing 
loss [7, 48]. In this study we investigated ion channels related to connexins in patients with 
altered hearing and detected the expression level of Cx26, Cx43 and Kir2.1 channels in the 
blood cells. Patients have hearing defects and these results highlight to the role of gap junc-
tions and hemichannels in K+ removal and recycling in the inner ear, as well as possible roles 
for nutrient passage in the cochlea [9, 26, 48].
2. Material and methods
2.1. Human patients
Eighty consecutive, non-randomized profoundly hearing-impaired cochlear implant candi-
dates were recruited in this study cohort; 45 females and 35 males aged between 0.5 and 
72 years (average: 25.8 ± 24.4 years). The control group was made up of 13 subjects with objec-
tively measured binaural normal hearing sensitivity; 7 females and 6 males aged between 3 
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and 59 years (average: 27.4 ± 17.2 years) (Tables 1 and 2). Details of patient demographics, 
clinical diagnoses, and genetic investigations are presented in Table 1. All patients in the dis-
eased group had nonsyndromic sensorineural hearing loss, without any organic abnormali-
ties (neither anatomical nor developmental alterations) including overlapping diseases. Prior 
to cochlear implantation, patients did not receive medication. The investigations conformed 
to the Declaration of Helsinki. Experimental protocols were authorized by the University of 
Szeged and National Scientific Research Ethical Review Boards (No. 38/2014). The blood cells 
were taken and kept in cold (4–6°C) for 2–4 h prior to investigations.
2.2. Objective tests used for the evaluation of hearing sensitivity
2.2.1. Impedance audiometry
2.2.1.1. Tympanometry
A measurement of compliance change in the middle ear apparatus to transmit sounds to the 
inner ear as air pressure is varied in the external auditory canal [49, 50]. Equipment used: 
r36m Clinical Middle Ear Analyzer (Resonance, Gazzaniga, Italy).
2.2.1.2. Acoustic reflex test
Following high intensity acoustic stimulation, a sudden decrease in compliance occurs with 
an approximate 10 ms delay as a consequence of the contraction of the stapedius muscle. 
Equipment used: r36m Clinical Middle Ear Analyzer (Resonance, Gazzaniga, Italy).
Patients Sex Age Diagnosis Mutation
1 F 5.0 ND NO
2 M 39.0 ND NO
3 F 59.0 ND NO
4 F 16.7 ND NO
5 F 57.9 ND NO
6 M 22.0 ND NO
7 M 23.9 ND NO
8 M 22.1 ND NO
9 F 24.0 ND NO
10 M 17.9 ND NO
11 F 17.9 ND NO
12 F 17.7 ND NO
13 M 3.0 ND NO
ND: Non-Diseased; F: female; M: male.
Table 1. Data of non-diseased patients without mutations in GJB2 (Cx26) genes in Hungarian population: non-diseased 
patients.
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Patients Sex Age Diagnosis Mutation
1 M 1.7 Hearing loss
2 M 46.3 Hearing loss
3 M 2.5 Hearing loss GJB2 (heterozygote c.35delG)
4 F 4.4 Hearing loss
5 F 1.1 Hearing loss
6 M 2.8 Hearing loss
7 M 16.1 Hearing loss
8 M 23.5 Hearing loss
9 M 1.4 Hearing loss GJB2 (homozygote c.35delG)
10 F 14.5 Hearing loss
11 F 26.9 Hearing loss
12 F 27.6 Hearing loss GJB2 (homozygote c.35delG)
13 M 14.5 Hearing loss
14 F 1.8 Hearing loss
15 F 65.7 Hearing loss
16 F 64.6 Hearing loss GJB2 (homozygote c.35delG)
17 M 2.1 Hearing loss GJB2 (heterozygote c.35delG)
18 M 70.4 Hearing loss
19 F 70.0 Hearing loss
20 F 41.9 Hearing loss
21 F 1.8 Hearing loss
22 F 71.0 Hearing loss
23 F 2.2 Hearing loss GJB2 (heterozygote missense c.101 T/C 
p.Met34Thr (rs35887622, CM077555, 
CM970679))
24 F 9.9 Hearing loss GJB2 (homozygote c.35delG)
25 M 6.9 Hearing loss GJB2 (heterozygote c.35delG)
26 F 1.9 Hearing loss GJB2 (homozygote c.35delG)
27 M 2.7 Hearing loss GJB2 (homozygote c.35delG)
28 M 1.3 Hearing loss
29 F 2.9 Hearing loss GJB2 (homozygote c.35delG)
30 M 5.4 Hearing loss GJB2 (heterozygote c.35delG)
31 M 69.6 Hearing loss
32 F 11.3 Hearing loss
33 F 54.0 Hearing loss
34 F 69.5 Hearing loss
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Patients Sex Age Diagnosis Mutation
35 F 23.7 Hearing loss
36 M 3.1 Hearing loss
37 M 61.6 Hearing loss
38 F 15.4 Hearing loss
39 F 27.7 Hearing loss
40 F 76.9 Hearing loss
41 F 41.7 Hearing loss
42 M 2.0 Hearing loss
43 M 1.2 Hearing loss
44 M 2.6 Hearing loss GJB2 (heterozygote missense c.119c/a 
p.Ala40Glu (rs111033296, CM051511)
45 F 48.0 Hearing loss
46 F 59.1 Hearing loss GJB2: c.101 T/C p.Met34Thr rs35887622 
homozygote,
GJB2: c.139G/T p.Glu47Ter rs104894398 
homozygote
47 M 52.7 Hearing loss GJB2: c.35delG homozygote
48 M 19.7 Hearing loss
49 M 2.6 Hearing loss GJB2 (homozygote c.35delG)
50 M 6.6 Hearing loss
51 M 58.5 Hearing loss
52 M 13.2 Hearing loss
53 F 27.3 Hearing loss
54 F 34.9 Hearing loss
55 F 58.9 Hearing loss
56 F 29.8 Hearing loss
57 F 49.2 Hearing loss
58 F 77.3 Hearing loss
59 M 51.2 Hearing loss
60 M 3.1 Hearing loss GJB2 (homozygote c.35delG)
61 M 52.6 Hearing loss
62 F 40.9 Hearing loss GJB2 (heterozygote c.35delG)
63 F 5.7 Hearing loss
64 M 1.5 Hearing loss GJB2 (homozygote c.35delG)
65 F 2.5 Hearing loss
66 F 2.0 Hearing loss
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2.2.2. Otoacoustic emission (OAE)
Spontaneous and evoked sound waves that originate from the inner ear are transmitted 
through the ossicles and the eardrum into the external auditory meatus can be measured. 
Equipment used: Eclipse EP15 (Interacoustics A/S, Middelfart, Denmark [51].
2.2.3. Auditory brain stem responses (ABR)
Auditory brain stem responses are far-field potentials that measure all ranges of the early 
auditory evoked potentials (AEP) using signal averaging [52, 53]. It consists of a series of seven 
waves (I-VII.) occurring within about 10 ms from stimulus onset [54]. Applied stimuli: Click 
and CE-Chirp LS. Equipment used: Eclipse EP15 (Interacoustics A/S, Middelfart, Denmark). 
Click stimulus: used to test the critical high frequency region (approximately 2–4 kHz). Chirp 
stimulus: applied to activate the entire cochlea instantaneously.
2.2.4. Auditory steady state responses (ASSR)
Auditory steady state responses are AEPs that are used to objectively estimate the hearing 
sensitivity in individuals with normal hearing sensitivity and with various degrees and 
configurations of sensorineural hearing loss (SNHL) [55]. Equipment used: Eclipse EP15 
(Interacoustics A/S, Middelfart, Denmark) [50, 55].
Patients Sex Age Diagnosis Mutation
67 F 64.6 Hearing loss *GJB3 (c.316C/T p.Arg106Cys 
(rs147106166) heterozygote)
68 F 2.8 Hearing loss
69 F 7.1 Hearing loss
70 M 23.7 Hearing loss
71 F 66.5 Hearing loss
72 M 68.7 Hearing loss
73 F 5.9 Hearing loss GJB2 (heterozygote c.35delG)
74 M 6.2 Hearing loss
75 F 20.9 Hearing loss
76 M 9.4 Hearing loss GJB2 (heterozygote c.35delG)
77 F 45.2 Hearing loss
78 M 1.4 Hearing loss
79 F 3.4 Hearing loss
80 F 55.8 Hearing loss
F: female; M: male.*Mutation of GJB3 gene.
Table 2. Data of hearing loss patients carrying mutations in GJB2 (Cx26) genes in Hungarian population: patients with 
hearing loss.




Peripheral blood samples were drawn from the affected patients (n = 80). Genomic DNA 
was isolated following the instructions of QIAamp DNA Blood Mini Kit (Qiagen, USA). The 
coding regions and the flanking introns of the GJB2, GJB3 and GJB6 genes were amplified by 
polymerase chain reaction (PCR) using DreamTaq Green PCR Master Mix (Thermo Scientific, 
USA). Primer sequences used for the genetic analyses were designed with Primer 3 (http://
bioinfo.ut.ee/primer3/) online software. The quality and quantity of PCR products were mea-
sured by electrophoresis on 2% agarose gel (SeaKem LE agarose, Lonza), which were used as 
templates for sequencing. Direct sequencing of PCR products was performed on a traditional 
capillary sequencer (ABI Prism 7000) and compared with the wild-type gene sequences using 
the Ensemble Genome Browser.
2.4. Immunofluorescence
Blood samples were collected in parallel for protein analyses in tubes containing EDTA as anti-
coagulant. Blood cells of non-diseased and hearing loss patients were washed with phosphate 
buffer saline (PBS, pH 7.3) and centrifuged gently. Cells, mostly lymphocytes, were attached 
to slides, blocked with 2% bovine serum albumin and incubated overnight at 4°C with mouse 
anti-Cx26 (1:100 dilution, Millipore, USA), or rabbit anti-Cx43 (1:100 dilution, Cell Signaling 
Technology, USA), or rabbit anti-Kir2.1 antibodies (1:100 dilution, Alomone Ltd., Jerusalem) 
with mouse anti-SAP97 (1:300 dilution, LifeSpan, USA) [48]. After washing with PBS, the cells 
were incubated with Alexa 488-labeled anti-rabbit IgG (1:400 dilution; Molecular Probes, USA) 
plus Cy3-conjugated anti-mouse IgG (1:400 dilution; Jackson Immuno Research Laboratories, 
Inc., USA) secondary antibodies and counterstained with 2,4 diamino-2-phenylindol (DAPI) 
(Hoechst 33258) for 10 minutes. Detection was performed using an Olympus FV1000 confocal 
laser scanning microscope (Olympus Life Science Europa GmbH, Hamburg, Germany). The 
scale bar was labeled in every figure (n = 2–3 specimens for each antibody staining) from 12 
patients and the analysis was performed using Fluoview ver. 4.0 programme.
3. Results
3.1. Examination of patients expecting cochlear implantation
The outer ear was inspected by physical examination and found to be anatomically and func-
tionally intact in all subjects prior to any hearing assessment (Figure 1A–H). Hearing sensitiv-
ity was subsequently evaluated with objective procedures, applying the crosscheck principle 
to achieve reliable results, confirmed by multiple analyses [49]. The middle ear is essentially 
an impedance matching system. Impedance is simply a measure of acceptance or rejection of 
the energy per unit time. While transmitted through the tympanic membrane and other struc-
tures of the middle ear, acoustic signals can be modified, depending on the mass, the elasticity 
and the resistance of the system that would determine the amount of energy accepted or 
reflected. The overall configuration of tympanometry and acoustic reflex tests provide greater 
authority and assurance in the evaluation of middle ear pathologies and conductive hearing 
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loss. Middle ear analysis was performed prior to any other tests to unquestionably exclude 
any pathology that might alter subsequent results [49, 50]. Otoacoustic emissions (OAEs) 
indicate the functional integrity of the outer hair cells in the inner ear [49, 51]. The source that 
generates retrograde sound transmission is the frequency following cell-vibration of the outer 
hair cells, representing their active, non-linear characteristics. There is a distinction between 
spontaneous emissions (SOAE) and evoked emissions (EOAE). Several modes of stimula-
tion and registration (i.e. post or pre-stimulatory) are known to provide information about 
outer hair cell function [49, 50]. Distortion product otoacoustic emission (DPOAE) [49, 51] is 
one of them. Representative results of a non-diseased subject (Table 1), (Figure 1A, C, E, G) 
and a hearing-impaired patient (Table 2), (Figure 1B, D, F, H) are presented. All curves are 
color-coded: red lines represent the right ear while blue lines represent the left ear. Figure 1A 
and B clearly shows that the active, non-linear vibrations of the outer hair cells to an exter-
nal sound stimulus are sensitively recordable with DPOAE exhibiting the normal function 
of the endocochlear cellular amplification mechanisms (Figure 1A). In hearing-impaired 
patients, DPOAE can be registered up to a moderate degree of sensorineural hearing loss; 
however, the signal tapers off beyond a certain extent (Figure 1B). Neural responses dur-
ing an auditory brainstem response test (ABR) are generated subcortically by the auditory 
nerve and subsequent brain stem fiber tracts and nuclei. Using either click or chirp stimuli is 
still the gold standard for electro-physiologically assessing the integrity of the auditory nerve 
and the brain stem pathways as they lead the electrical stimuli towards the cortex [52–55] 
(Figure 1C and D). Neuronal junction points in the brainstem as generator relay structures 
are identified in the form of waves on the electrophysiological recordings in normal subjects 
(Figure 1C); while these points are not registered in patients with a profound hearing loss 
(Figure 1D). Using CE Chirp-LS stimuli (Figure 1E and F) while registering ABRs, the syn-
chronous activation is achieved in the cochlea, thus a more prominent wave IV-V is observed 
in a non-diseased patient (Figure 1E). In patients with profound hearing loss, ABRs are miss-
ing (Figure 1F). Auditory steady state responses on amplitude-modulated stimuli are highly 
relevant, since it takes many years to objectively estimate hearing sensitivity in individuals 
with normal hearing and with various degrees and configurations of SNHL. The objective 
estimation of hearing sensitivity is performed by auditory steady-state response (ASSR) tests 
(Figure 1G and H). In a non-diseased subject, normal thresholds were registered on all the 
measured frequencies (Figure 1G); while a profound hearing loss is demonstrated in a patient 
with hereditary sensorineural deafness (Figure 1H).
3.2. Mutation of connexin genes in blood cells in patients with hearing loss
In all patients the most frequently occurring GJ genes in the cochlea were tested for mutations 
of GJB genes from DNA of blood cells as described above. Figure 2 shows the distribution in 
patients from Hungary involving 13 non-diseased patients and 80 patients selected for cochlear 
implantation. The results of the mutation analysis of GJB2, GJB3 and GJB6 genes are shown in 
Figure 2A. 25.0% of hearing loss patients carried a mutation in the GJB2 gene, and only 1 out of 
80 patients (1.2%) had a mutation in the GJB3 gene (Figure 2A). Mutations in GJB6 genes were 
not detected in this study (Table 1). In the ancestors of the Hungarian Caucasian population, 
the 35delG mutation in the GJB2 gene appeared most frequently in homozygous state (50%) 
(Figure 2B) and c.35delG (p.Gly12ValfsTer2 (rs80338939)) in heterozygotes (50%). Among the 
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heterozygotes, the tests showed 35% mutations of heterozygote c.35delG p.Gly12ValfsTer2 
(rs80338939), 5% heterozygote missense c.101T>C p.Met34Thr (rs35887622), 5% heterozygote 
missense c.119C>A p.Ala40Glu (rs111033296) and 5% of compound heterozygous c.101T>C 
Figure 1. Objective clinical measures of the auditory function in patients with hearing loss. Representative results of a 
non-diseased patient (A, C, E, G) and a patient with impaired hearing (B, D, F, H) are presented. All curves are color-coded. 
Red represents the right ear, and blue represents the left ear. A-B: The active, non-linear vibrations of the outer hair cells to 
external sound stimuli are sensitively recordable with the distortion product otoacoustic emission test (DPOAE) exhibiting 
the normal function of the endocochlear cellular amplification mechanisms (A). In hearing impaired patients, DPOAE can 
be registered up to a moderate degree of sensorineural hearing loss. However, the signal tapers off beyond a certain extent 
(B). C-D: Auditory brainstem response tests (ABR) precisely reveals the functional integrity of the vestibulocochlear nerve 
leading the electrical stimuli towards the cortex. Neuronal junction points in the brainstem as generator relay structures 
are identified in the form of waves in the electrophysiological recordings in normal subjects (C); however, they are not 
present in patients with a profound hearing loss (D). E-F: The objective estimation of hearing sensitivity was performed 
by auditory steady-state response (ASSR) tests. In a non-diseased subject, normal thresholds were registered on all the 
measured frequencies (E), while a profound hearing loss is shown in a patient with hereditary sensorineural deafness (F). 
G-H: Used while registering ABRs, synchronous activation is achieved in the cochlea, thus a more prominent CE chirp-LS 
stimuli wave IV-V is observed in a non-diseased subject (G). In patients with profound hearing loss, ABRs are missing (H).
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p.Met34Thr (rs35887622), GJB2: c.139G>T p.Glu47Ter (rs104894398). The distribution of these 
ratios for homozygotes and heterozygotes may change with time, but the rate of this change 
cannot be estimated at this moment.
3.3. Distribution of connexins and Kir2.1 ion channels with modulators on blood 
cells
The expression of Cx26 and Cx43 channel proteins was abundant in non-diseased patients 
(control 1 and 2) but much poorer in blood cells of deaf patients as seen in Figure 3 and 
variable in hearing loss patients (see 1–3 on Figure 4). In all cells, the nuclei were coun-
terstained with DAPI (blue) and scale bars are shown on each image. Thirteen patients 
with hearing loss were tested for ion channels and compared to controls (with same age 
and sex) in each experiment. The protein pattern of both Cx26 and Cx43 changed on the 
surface of blood cells (Figures 3 and 4), appearing as large patches in the control cells and 
reorganized in smaller groups of connexins in diseased cells. Furthermore, the shape of the 
area around the nucleus was round in diseased cells and the cytosol was disintegrated. The 
protein level of Cx26 was variable on the surface of blood cells from patients with hearing 
loss. We could not identify the GJB2 gene mutation in Patient 1, but Patient 2 and 3 showed 
mutations with decreased protein level of Cx26. We suppose that Patient 1 has a mutation 
in another type of gene.
The Kir2.1 ion channels colocalized with SAP97 protein in non-diseased patients, but we 
determined only partial or no overlayed channel complexes (Figure 5) in cells from cochlear 
implant candidates. The protein pattern was altered and the levels were decreased in hearing 
loss patients compared to controls. The SAP97 anchoring protein is redistributed in the blood 
cells and do not colocalize often with Kir2.1 channels in diseased cells. The levels of Kir2.1 
Figure 2. Genetic mutations for GJB genes were tested in hearing loss patients prior to implantation (n = 80). (A) 
Prevalence of GJB2 and GJB3 gene mutations in subjects with non-syndromic hearing impairment (n = 21/80). (B) 
Prevalence of different GJB2 mutations in subjects with non-syndromic hearing impairment (n = 20/80).
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Figure 4. Alteration of protein levels of connexin43 ion channels in blood cells in patients with deafness. Representative 
figures from non-diseased and hearing loss patients. Cx43: Connexin43; DAPI: 2,4-diamino-2-phenylindole.
Figure 3. Pattern of connexin26 ion channels on blood cells of patients expecting cochlear implantation. Cx26: 
Connexin26, DAPI: 2,4-diamino-2-phenylindole.
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protein were varied in each cochlear implant candidates, just as in Patient 1 compared to 
Patient 2 or 3. The amount of SAP97 declined in the lymphocytes of Patient 2 and 3 with GJB2 
gene mutations. The Kir2.1 channels did not perfectly colocalize with SAP97 in the lympho-
cytes of Patients 1– 3 with hearing loss (Figure 5).
4. Discussion
The main purpose of this study was to detect the mutations of genes GJB2, GJB3 and GJB6 as 
well as the translated proteins Cx26, Cx43 and Kir2.1 ion channels from blood cells in cochlear 
implant candidates. The cochlear implantation was required in hearing impaired patients 
for based on indication criteria. Hearing sensitivity was evaluated with objective methodolo-
gies [56], applying the crosscheck principle. The outer and middle ear anatomy and function 
proved to be normal in all the recruited subjects of this cohort.
The study provided the following key results: (1) the different GJB mutations were detected 
in hearing loss in 50% homozygote and 50% heterozygote form for GJB genes in a Hungarian 
population. (2) Cx43 levels decreased moderately in blood cells. (3) Our investigation 
revealed a reduced level for Kir2.1 channels as well as for the SAP97 protein. (4) The extent 
of colocalization of Kir2.1 ion channels with SAP97 anchoring proteins was less marked 
or partially redistributed in blood cells from patients with hearing loss. (5) Cx26 mutation 
impacts hearing loss.
Figure 5. The disrupted protein pattern and coexpression of Kir2.1 ion channel with declined SAP97 on blood cells of 
hearing loss patients. SAP97: Synapse-associated protein 97; DAPI: 2,4-diamino-2-phenylindole.
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4.1. Significance of connexins in hearing system and alteration in deafness
These data are consistent with earlier reports on the decrease of GJB2 gene expression in deaf-
ness [7, 57], and this study is the first to demonstrate the declined Cx26 protein level in patients 
carrying these mutations. Recently, more than 100 mutations have been reported, among which 
the GJB2 gene mutations are the most common cause of nonsyndromic deafness [1]. In this 
study we demonstrated a similar ratio of GJB2 gene mutations in a Hungarian population in 
accordance with the earlier findings of Nagy et al. [7]. Additionally, more heterozygote forms 
were identified in this investigation. The position of joint mutations differs across many popu-
lations. This very likely holds true for other genes as well, but GJB2 gene is probably the most 
examined gene among the genes involved in hearing-related problems. The allelic frequency 
of three GJB2 gene mutations have been shown to exhibit differences based on ethnicity, which 
in some cases also translated to geographic regions [11]. The 35delG mutation of the coding 
exon of GJB2 gene has a frequency of 2–4% in the Caucasian population [58]. Geographically 
this holds true for Europe, the Middle East and some populations in North America.
The GJB2 gene encodes the Cx26 protein, which assembles to form channels between the 
cells in the cochlea. These gap junction proteins allow the rapid removal of K+ from the base 
of hair cells, resulting in the recycling of this ion back to the endolymph to maintain the 
cochlear homeostasis in humans [59]. Kamiya et al. investigated the expression of Cx26 and 
Cx30 in the gap junction macromolecular complex [60], where Cx26 is the most abundant 
channel in the cochlea of mice. They concluded that the disruption of Cx26 was the earliest 
alteration of the Cx26-dependent gap junction plaque during the embryonic development of 
mice with connexin-associated deafness. The degradation of the gap junction macromolecu-
lar complex leads to loss of hearing function [60] caused by diets [61].
The abnormal or missing gap junctions likely alter the level of potassium ions, which may 
affect the function and survival of cells that are essential for hearing in the inner ear. The 
spatial and temporal heteromeric associations of Cx26 and Cx30 proteins in the inner ear 
have been confirmed earlier [26, 62]. This finding has not been reconfirmed until now. Forge’s 
results had an essential role to understand the pathophysiologic processes of nonsyndromic 
deafness caused by mutations in GJB2 genes.
Previously, we have demonstrated that the Cx26 mutation frequently occurs in the Hungarian 
population [7]. In this study we demonstrated that the ratio of homozygotes and heterozy-
gotes is 1.0:1.0 in the mutated GJB2 genes, which suggests that the frequency of heterozygotes 
is rather high in hearing impaired patients. Further investigations are required to identify 
additional mutated genes. The combination of heterozygote forms of additional channels 
may also be involved in the causes leading to deafness in the Caucasian population, because 
about 73.8% of hearing impaired subjects is not carriers for mutations of the GJB2 gene.
Connexins are 25% more abundant in the sensory epithelial cells of the inner ear than in mam-
malian supporting cell types and these cells infrequently contain more than 100,000 channels. 
Forge and co-workers have demonstrated [62] that four connexin isotypes, Cx26, Cx30, Cx31 
and Cx43, can be found in different mammalian species, in the cochlea and three of them, 
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Cx26, Cx30 and Cx43, in the vestibular organs. The spatial distribution of connexins in the 
inner ear has been extensively investigated and it was suggested that these connexin channels 
are isolated both spatially and functionally. The Cx26 and Cx30 are found in supporting cells 
of the organ of Corti, in the basal cell region of the stria vascularis, and in type 1 fibrocytes 
of the spiral ligament, but no other connexin type was detected in this area. Cx31 localizes 
around the type 2 fibrocytes and below the spiral prominence. Cx30 was not expressed here 
and the amount of Cx26 expression was low in the above areas [62]. Cx43 was only detected 
in one region where “tension fibrocytes” line the inner aspect of the otic capsule. It is an 
important result that Cx26 colocalizes with Cx30 as detected by electron microscopic and 
immunoprecipitation methods for protein expression.
The majority of gap junction forming proteins in the inner ear potassium-recycling pathway 
includes Cx26, Cx30 and Cx43. The heteromeric association of Cx26 and Cx30 proteins indi-
cates a fine regulation in the connexin composition of the gap junction channels in the inner 
membrane of the cochlea, and the altered potassium homeostasis might also be related to the 
redistributed ion channels on blood cells. The heteromeric coexpression of Cx40-Cx43-Cx45 
was evaluated by Desplantez et al. [63, 64] in liver cells, and low levels of Cx40/Cx43 coex-
pression was detected in heart tissues demonstrating that the Cx40:Cx43 ratio regulates the 
composition and electrical properties of gap junctions [65–68], which may also be the case 
in the cochlea.
The age of the 35delG mutation was estimated by Van Lear and co-workers [12]. This muta-
tion was tested in ancestors for about 500 generations, indicating an approximate age of 
10,000 years in various populations. The mutations in the Hungarian Caucasian population 
demonstrate a European average.
We saw a high expression of Cx26 and Cx43 proteins in the blood cells of non-diseased patients 
where the high intensity staining on the surface of cells indicated a high abundance of Cx26. 
In the presence of the GJB2 gene mutation, the Cx26 protein level decreased and the pattern 
of the distribution was disrupted. These results suggest that the expression of GJB2 gene is 
regulated at the level of transcription and translation in non-diseased patients. Furthermore, 
it supported the results that the GJB2 gene deficiency is presumably associated with cochlear 
developmental disorders [66].
Our results indicate that the absence or a reduced presence of Cx26 channels contributes to 
the development of deafness in humans, which is in support of earlier results [1, 7, 57]. The 
widely distributed Cx26 and Cx30 and Cx43 proteins have an essential role in the regulation 
of early ear development [9, 26, 35] and also in the regulation of potassium pathways in the 
inner ear of adults [26, 62, 67].
4.2. The possible role of Kir2.1 ion channels in the cochlea
Kir2.x ion channels have an important physiological function in transporting potassium 
ions back into the cells, but the mutations of these ion channels are rarely detected. The role 
of Kir2.1 ion channels, well-known in Andersen-Tawil syndrome, has only recently been 
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confirmed for deafness [36, 37, 69], and this suggests the importance of in the auditory system. 
The spatial and temporal localization of Kir2.x channels has been mapped in the inner ear by 
Forge et al. [62], Jagger et al. [26] and its significance has been described by Meredith et al. 
[70]. Kir2.1 was characterized as a strong inwardly rectifying ion channel in the vestibular 
type II hair cells by Zampini et al. [18], Correia et al. [71] in avian and mammalian settings too 
[47, 69]. An inwardly rectifying potassium channel itself, Kir5.1 plays a vital role in regulating 
cochlear K+ circulation which is necessary for normal hearing, and it has age-related reduction 
in expression [71] just like SAP97, but contrary to the Kir2.1 ion channels [45]. The develop-
mental study by Ruan et al. [20, 21] carried out in mouse has shown the temporal pattern 
of Kir2.1 channels in different parts of the hearing system. Kir2.1 has a temporal expression 
in the hair cells of mouse cochleae that correlates with the functional maturation of the hair 
cells and the neurons. The stronger signals were generally detected in the apical parts of the 
cochlea and on row 3 outer hair cells after birth. However, the Kir2.1 ion channels in human 
adults have been detected mostly in the vestibular system. In all types of cells the mutations 
of these channels still indicated that the homomer and heteromer Kir2.x channel compositions 
are necessary in the mammalian inner ear. Lewin and Holt [47], and also Meredith and Rennie 
[70] identified the functional contribution of Kir2.1 in the IK1 current in utricle hair cells. They 
demonstrated that Kir2.1 is required for IK1 currents in type II utricle hair cells and that Kir2.1 
contributes to the hyperpolarized resting potentials [46] and also to the fast, small amplitude 
receptor potentials.
The effective functioning of the Kir2.x protein tripartite complex, requires an association of 
proteins involving SAP97 and calcium calmodulin kinase II (CaMKII) with Kir2.1 ion chan-
nels, and Kir2.6 ion channel also has an essential role to deliver the matured Kir2.x protein 
to the membrane surface [42, 43]. In this study, we showed that the amount of Kir2.1 channel 
was close to the control in hearing loss patients where we could not detect GJB2 gene muta-
tions. The low level of SAP97 anchoring protein decreased drastically in hearing loss patients. 
Our results confirmed the colocalization of Kir2.1 ion channel with SAP97 anchoring protein 
in non-diseased patients but only partial colocalization with disrupted clustering occurred on 
the surface of blood cells in patients with deafness. This redistribution of the Kir2.1 channel 
complex, and also the clearly visible reorganization of Cx26 and Cx43 channels, suggests the 
instability of Kir2.1 and connexin macromolecule complexes in blood cells. This redistribu-
tion of Kir2.1 ion channels and Cx26 on the surface of blood cells may lead to a weakened 
physiological function of Kir2.1 channels and gap junctions, which, in turn, may influence the 
potassium homeostasis in the sensorineural system [73, 74]. These direct or indirect interac-
tions are essential for the normal physiological function of the Kir2.1 complex and inward 
rectifier currents contributing to normal potassium ion homeostasis [71, 72].
The development of new diagnostic techniques for molecular biology analysis together 
with deep insights into molecular physiology requires subcellular nanotechnology tools in 
biomedical research and clinical diagnostics. In this study, we report on hearing impaired 
patients with a series of hearing screenings using modern equipment, and we have developed 
a new molecular method to study the critical potassium ion channels contributing to normal 
cochlear function.
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5. Conclusion
Altered expression of Cx26 with Kir2.1 ion channel complex in hearing loss patients pro-
foundly determines the potassium-recycling pathway and the alteration of these channels in 
blood cells in deafness detectable using molecular tools.
The Kir2.x ion channels and connexin channels may have an essential role in the IK1 currents 
of the cochlea and vestibule during the development process and may serve as diagnostic 
markers in the early stage of the pathophysiology of hearing loss.
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Abbreviation
ABR auditory brain stem responses
AEP auditory evoked potentials
AP action potential
ARNSHL autosomal recessive non-syndromic hearing loss
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ASSR auditory steady-state responses







DBS dried blood spots
DNA deoxyribonucleic acid
DPOAE distortion product otoacoustic emission
EDTA ethylenediaminetetraacetic acid
EOAE evoked otoacoustic emissions
GJB2 gap junction protein beta 2
GJB3 gap junction protein beta 3
GJB6 gap junction protein beta 6
HC hemichannel
Kv-type voltage-gated potassium channel
Kir2.x potassium inward-rectifier ion channel 2.x
MAGUK membrane associated guanylate kinase
OAE otoacoustic emission
PCR polymerase chain reaction
PDS Pendred syndrome
PM plasma membrane
SAP97 synapse-associated protein 97
SNHL sensorineural hearing loss
SOAE spontaneous otoacoustic emission
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